Cargando…
REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial
INTRODUCTION: Liver disease mortality and morbidity are rapidly rising and liver transplantation is limited by organ availability. Small scale human studies have shown that stem cell therapy is safe and feasible and has suggested clinical benefit. No published studies have yet examined the effect of...
Autores principales: | King, A, Barton, D, Beard, H A, Than, N, Moore, J, Corbett, C, Thomas, J, Guo, K, Guha, I, Hollyman, D, Stocken, D, Yap, C, Fox, R, Forbes, S J, Newsome, P N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368910/ https://www.ncbi.nlm.nih.gov/pubmed/25795699 http://dx.doi.org/10.1136/bmjopen-2015-007700 |
Ejemplares similares
-
Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial
por: Newsome, Philip Noel, et al.
Publicado: (2017) -
The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2015) -
Long-term Outcome of Autologous Hematopoietic Stem Cell Infusion in Cirrhosis: Waning Effect over Time
por: Sharma, Mithun, et al.
Publicado: (2020) -
Myeloablative treatment supported by autologous stem cell infusion with neuroblastoma.
por: Ryu, Kyung Ha, et al.
Publicado: (2003) -
Infusion of Autologous Retrodifferentiated Stem Cells into Patients with Beta-Thalassemia
por: Abuljadayel, Ilham Saleh, et al.
Publicado: (2006)